If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarratt Redrow Regulatory News (BTRW)

Share Price Information for Barratt Redrow (BTRW)

Share Price is delayed by 15 minutes
Get Live Data
283.30    0.00 (0.00%)
Bid:
250.00
Ask:
316.00
Spread: 66.00 (26.40%)
Market Cap: £3.97b
BTRW Live PriceLast checked at - London Stock Exchange

Intraday Barratt Redrow Share Chart

CMA Consults on Proposed Housebuilder Commitments

9 Jul 2025 07:08

RNS Number : 2608Q
Barratt Redrow PLC
09 July 2025
 

9 July 2025

 

Barratt redrow plc

UK Competition and Markets Authority consults on proposed commitmentsin housebuilding investigation

Barratt Redrow plc ("Barratt Redrow") notes the UK Competition and Markets Authority's ("CMA") announcement today that it is inviting views on voluntary commitments offered by Barratt Redrow and six other UK housebuilders[1] ("the Parties") as part of the CMA's ongoing investigation in the housebuilding sector.

 

Barratt Redrow has engaged proactively and constructively with the CMA throughout its investigation, including by voluntarily offering binding commitments alongside the other Parties in response to the potential concerns investigated by the CMA, and with a view to resolving expeditiously the investigation. The offer of voluntary commitments does not constitute an admission of any wrongdoing by Barratt Redrow and nothing in the commitments may be construed as implying that Barratt Redrow agrees with any concerns expressed by the CMA in the investigation.

 

The Parties' proposed commitments include making a collective payment of £100 million to His Majesty's Government to be disbursed to the affordable homes programmes in England, Scotland, Wales and Northern Ireland. Barratt Redrow's share of the payment is expected to be £29 million[2].

 

Barratt Redrow welcomes the CMA's consultation on the voluntary commitments and will continue to work constructively with the CMA throughout the process.

For further enquiries, please contact:

Analyst/investor enquiries:

John Messenger, Group Investor Relations Director07867 201 763

Media enquiries:

Tim Collins, Group Corporate Affairs Director020 7299 4874

Brunswick:

Rosie Oddy / Peter Hesse020 7404 5959

www,barrattredrow.co.uk

 

Barratt Redrow plc LEI: 2138006R85VEOF5YNK29

 

Barratt Redrow plc's next scheduled announcement is the FY25 Trading Update on Tuesday 15 July 2025.

 

 


[1] Bellway plc, The Berkeley Group plc, Bloor Homes Limited, Persimmon plc, Taylor Wimpey plc, and Vistry Group plc.

[2] The £29 million is the total being paid by Barratt and Redrow combined now as Barratt Redrow plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGGNMRFGKZZ
Date   Source Headline
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSFull year results for the period end 29 June 2025
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20259:16 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSRule 19.6(c) confirmation of post-offer statements
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20259:23 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20258:38 amRNSBlock listing Interim Review
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 202512:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.